Synuclein Publications
-
(2019)
Banks,S., Medeiros, A., McQuillan, M., Busch, D., Ibarraran-Viniegra, A., Sousa, R., Lafer, E., Morgan, J.,
Hsc70 Ameliorates the Vesicle Recycling Defects Caused by Excess α-Synuclein at Synapses.
ENEURO; DOI: https://doi.org/10.1523/ENEURO.0448-19.2020.
-
(2018)
Li-fan Zhang, Xiao-lin Yu, Mei Ji, Shu-ying Liu, Xiao-ling Wu, Yu-jiong Wang, Rui-tian Liu
Resveratrol alleviates motor and cognitive deficits and neuropathology in the A53T α-synuclein mouse model of Parkinson's disease.
Food & Function; DOI: 10.1039/c8fo00964c.
-
(2018)
Wang,X., Chi,J., Huang,D., Ding,L., Zhao,X., Jiang,L., Yu,Y., Gao,F.
α-synuclein promotes progression of Parkinson's disease by upregulating autophagy signaling pathway to activate NLRP3 inflammasome.
Spandidos Publications; https://doi.org/10.3892/etm.2019.8297.
-
(2018)
Markus Mandler, Edward Rockenstein, Cassia Overk, Michael Mante, Jazmin Florio, Anthony Adame, Changyoun Kim, Radmila Santic, Achim Schneeberger, Frank Mattner, Sabine Schmidhuber, Gergan Galabova, Brian Spencer, Eliezer Masliah, Robert A.Rissman
Effects of single and combined immunotherapy approach targeting amyloid β protein and α-synuclein in a dementia with Lewy bodies-like model..
Alzheimers Dement.; doi: 10.1016/j.jalz.2019.02.002.
-
(2018)
Ying Guo, Xinbing Wei, Hua Yan, Yue Qin, Shaoqi Yan, Jia Liu, Yong Zhao, Fan Jiang, and Haiyan Lou
TREM2 deficiency aggravates α-synuclein–induced neurodegeneration and neuroinflammation in Parkinson’s disease models..
FASEB J.; DOI: 10.1096/fj.201900992R.
-
(2018)
Sarah Jinn, Cornelis Blauwendraat, Dawn Toolan, Cheryl A Gretzula, Robert E Drolet, Sean Smith, Mike A Nalls, Jacob Marcus, Andrew B Singleton, David J Stone
Functionalization of the TMEM175 p.M393T Variant as a risk factor for Parkinson Disease..
Hum Mol Genet.; DOI: 10.1093/hmg/ddz136.
-
(2018)
Veselin Grozdanov, Luc Bousset, Meike Hoffmeister, Corinna Bliederhaeuser, Christoph Meier, Karine Madiona, Laura Pieri, Martin Kiechle, Pamela J. McLean, Jan Kassubek, Christian Behrends, Albert C Ludolph, Jochen H Weishaupt, Ronald Melki, Karin M Danzer
Increased Immune Activation by Pathologic α‐Synuclein in Parkinson's Disease.
Annals of Neurology; https://doi.org/10.1002/ana.25557.
-
(2018)
Monika Rabenstein Daniela Besong Agbo, Elias Wolfah, Judith Dams, Marina Nicolai, Andreas Roeder, Michael Bacher, Richard C. Dodel, Carmen Noelker
Effect of naturally occurring α-synuclein-antibodies on toxic α-synuclein-fragments.
Neuroscience Letters; https://doi.org/10.1016/j.neulet.2019.04.004.
-
(2018)
Izumi Yasuhiko, Kondo, Naoto, Takahashi Ryosuke, Akaike Akinori, Kume Toshiaki
Reduction of Immunoreactivity Against the C-Terminal Region of the Intracellular α-Synuclein by Exogenous α-Synuclein Aggregates: Possibility of Conformational Changes..
Journal of Parkinson’s Disease; doi: 10.3233/JPD-160835..
-
(2018)
Mingming Xu, Wendy Loa-Kum-Cheung, Haiyan Zhang, Ronald J. Quinn, George D. Mellick
Identification of a New α-Synuclein Aggregation Inhibitor via Mass Spectrometry Based Screening.
ACS Chem. Neurosci.; https://doi.org/10.1021/acschemneuro.9b00092.
